Creative Medical Technology launches $6M share offering as stock slides 35%
What's the deal? Creative Medical Technology HoldingsDealroom has a profile for this one. Try Dealroom → has announced a public offering of up to 3.05 million shares of common stock, aiming to raise $6,008,500.
The shares are priced at an assumed $1.97 each and include warrants for an additional 6.09 million shares.
The post-IPO equity round is intended to fund the company's future growth.
Why now? The raise comes despite a tough year for the stock, which has fallen 35%.
Shares hit a 52-week low on Friday, dropping 33% in a single session.
What could go wrong? Issuing new shares and warrants dilutes existing shareholders, a risk that grows when the stock is already weak.
Investor confidence appears thin, and the added supply could pressure the price further.
The signal: The dilutive raise marks a precarious moment for Creative Medical, an early-stage company betting on regenerative therapies across immunology, urology, neurology, and orthopedics — capital-intensive fields that demand long runways. With shares at 52-week lows alongside fellow micro-caps Baiya International and GD Culture, the offering reflects a broader pattern of small-cap firms leaning on dilutive instruments to fund growth they cannot yet finance through performance.
Read more: Intellectia
Image credit: Tareq Salahuddin
